Economic burden of adult pharyngitis: The payer's perspective

Value in Health

Volumn 11, Issue 4, 2008, Pages 621-627

  Salkind, Alan R ^a   Wright, Julie M ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adults; Antibiotic resistance; Cost of illness analysis; Pharyngitis

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; ERYTHROMYCIN; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANAPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; COST CONTROL; COST OF ILLNESS; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HUMAN; PHARYNGITIS; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RASH; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TREATMENT INDICATION;

EID: 47749138204     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2007.00286.x     Document Type: Article

References (47)

1. Schappert SM, Burt CW. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency rooms: United States, 2001-2002. National Center for Health Statistics. Vital Health Stat 2006 13 : 1 66.
2. Bisno AL. Primary care: acute pharyngitis. N Engl J Med 2001 344 : 205 11.
3. Linder JA, Chan J, Bates DW. Evaluation and treatment of pharyngitis in primary care practice. Arch Intern Med 2006 166 : 1374 9.
4. Ladd E. The use of antibiotics for viral upper respiratory tract infections: an analysis of nurse practitioner and physician prescribing practices in ambulatory care, 1997-2001. J Am Acad Nurse Pract 2005 17 : 416 24.
5. Linder JA, Stafford RS. Antibiotic treatment of adults with sore throat by community care physicians. A national survey, 1989-1999. JAMA 2001 286 : 1181 6.
6. Howard DH, Scott RD II. The economic burden of drug resistance. Clin Infect Dis 2005 41 (Suppl. S283 6.
7. Tleyjeh IM, Tlaygeh HM, Hejal R, et al. The impact of penicillin resistance on short-term mortality in hospitalized adults with pneumococcal pneumonia: a systematic review and meta-analysis. Clin Infect Dis 2006 42 : 788 97.
8. Rubin RJ, Harrington CA, Poon A, et al. The economic impact of Staphylococcus aureus infection in New York City Hospitals. Emerg Infect Dis 1999 5 : 9 17.
9. Institute of Medicine. Antimicrobial Resistance: Issues and Options. Workshop Report. Washington, DC : National Academy Press, 1998.
10. Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infections in the United States. Arch Intern Med 2003 163 : 487 94.
11. Snow V, Mottur-Pilson C, Cooper RJ, Hoffman JR. Principles of appropriate antibiotic use for acute pharyngitis in adults. Ann Intern Med 2001 134 : 506 8.
12. Bisno AL, Gerber MA, Gwaltney JM Jr. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis 2002 35 : 113 25.
13. Birnbaum HG, Morley M, Greenberg PE, Colice GL. Economic burden of respiratory infections in an employed population. Chest 2002 122 : 603 11.
14. Rice DP. Cost-of-illness studies: fact or fiction? Lancet 1994 344 : 1519 20.
15. Byford S, Torgerson DJ, Raftery J. Cost of illness studies. Br Med J 2000 320 : 1335.
16. Segel JE. Cost-of-illness studies: a primer. 2006. Available from: http://www.rti.org/pubs/COI_Primer.pdf [Accessed March 1, 2007].
17. Drug Topics Red Book. Montvale, NJ : Thomson Healthcare, 2006.
18. Salkind AR, Cuddy PG, Foxworth JW. Is this patient allergic to penicillin? An evidence-based analysis of the likelihood of penicillin allergy. JAMA 2000 285 : 2498 505.
19. Harbath S, Albrich W, Brun-Buisson C. Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective. Emerg Infect Dis 2002 12 : 1460 7.
20. Kristinsson KG. Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci. Microb Drug Resist 1997 3 : 117 23.
21. Guillemot D, Varon E, Bernède C, et al. Reduction of antibiotic use in the community reduces the rate of colonization with penicillin-G nonsusceptible Streptococcus pneumoniae. Clin Infect Dis 2005 41 : 930 8.
22. Lipsitch M. Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae. Clin Infect Dis 2001 32 : 1044 54.
23. McGowan JE Jr. Economic impact of antimicrobial resistance. Emer Infect Dis 2001 7 : 286 92.
24. Phelps CE. Bug/drug resistance. Sometimes less is more. Med Care 1989 27 : 194 203.
25. Hoban D, Waites K, Felmingham D. Antimicrobial susceptibility of community-acquired respiratory tract pathogens in North America in 1999-2000: findings of the PROTEKT surveillance study. Diagn Microbiol Infect Dis 2003 45 : 251 9.
26. Jacobs MR, Felmingham D, Appelbaum PC, et al. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 2003 52 : 229 46.
27. De Meyere M, Mervielde Y, Verschraegen G, Bogaert M. Effect of penicillin on the clinical course of streptococcal pharyngitis in general practice. Eur J Clin Pharmacol 1992 43 : 581 5.
28. Dagnelie CF, Van der Graaf Y, De Melker RA. Do patients with sore throat benefit from penicillin? A randomized double-blind placebo-controlled clinical trial with penicillin V in general practice. Br J General Pract 1996 46 : 589 93.
29. Howe RW, Millar MR, Coast J, et al. A randomized controlled trial of antibiotics on symptom resolution in patients presenting to their general practitioner with a sore throat. Br J Gen Pract 1997 47 : 280 4.
30. Gordis L. The virtual disappearance of rheumatic fever in the United States: lessons in the rise and fall of disease. T. Duckett Jones Memorial Lecture. Circulation 1985 72 : 1155 62.
31. Howie JGR, Foggo BA. Antibiotics, sore throats and rheumatic fever. J R Coll Gen Pract 1985 35 : 223 4.
32. Zwart S, Sachs APE, Ruijs GJHM, et al. Penicillin for acute sore throat: randomised double blind trial of seven days versus three days or placebo in adults. Br Med J 2000 320 : 150 4.
33. Middleton DB, D'Amico F, Merenstein JH. Standardized symptomatic treatment versus penicillin as initial therapy for streptococcal pharyngitis. J Pediatr 1988 113 : 1089 94.
34. Seppälä H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 1997 337 : 441 6.
35. Martin JM, Green M, Barbadora KA, Wald ER. Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh. N Engl J Med 2004 346 : 1200 6.
36. Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci USA 1999 96 : 1152 6.
37. Levin BR, Lipsitch M, Perrot V, et al. The population genetics of antibiotic resistance. Clin Infect Dis 1997 24 (Suppl. S9 16.
38. Boxerbaum B. Prevention of streptococcal neurosis. Prim Care 1981 8 : 583 91.
39. Butler CC, Rollnick S, Pill R, et al. Understanding the culture of prescribing: qualitative study of general practitoners' and patients' perceptions of antibiotics for sore throats. Br Med J 1998 317 : 637 42.
40. Cowan PF. Patient satisfaction with an office visit for the common cold. J Fam Pract 1987 24 : 412 13.
41. Little P, Williamson I, Warner C, et al. Open randomized trial of prescribing strategies in managing sore throat. Br Med J 1997 314 : 722 7.
42. Little P, Gould C, Williamson I, et al. Reattendance and complications in a randomised trial of prescribing strategies for sore throat: medicalising effect of prescribing antibiotics. Br Med J 1997 315 : 350 2.
43. McGowan JE Jr. Minimizing antimicrobial resistance: the key role of the infectious diseases physician. Clin Infect Dis 2004 38 : 939 42.
44. Arnold SR, Straus SE. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst Rev 2006 4 : CD 003539.
45. Van Howe RS, Kusnier LP, II. Diagnosis and management of pharyngitis in a pediatric population based on cost-effectiveness and projected health outcomes. Pediatrics 2006 117 : 609 19.
46. Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med 1995 333 : 1618 24
47. Musher DM, Spindel SJ. Community-acquired pneumonia. Curr Top Infect Dis 1996 16 : 102 24.